Drugs · acquisition-cost intelligence
EX-LAX REGULAR STRENGTH STIMULANT LAXATIVE
Sennosides· ingredient sennosides, USP· SENNOSIDES 15 mg/1; SENNOSIDES A AND B 15 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.06732
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other sennosides, USP products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| CAREALL Sennosides | $0.02526 | −$0.04210 |
| Colace | $0.03053 | −$0.03680 |
| GeriCare Senna Syrup | $0.04200 | −$0.02530 |
| Chocolated Laxative | $0.10625 | +$0.03890 |
| HEB Maximum strength Laxative pills | $0.11625 | +$0.04890 |
| Senokot | $0.41634 | +$0.34900 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.